SARS-CoV-2 Disrupts the Immune Response in Intestinal Organo

SARS-CoV-2 Disrupts the Immune Response in Intestinal Organoids


SARS-CoV-2 Disrupts the Immune Response in Intestinal Organoids
April 27, 2021
The researchers were able to monitor the virus's growth in organoids derived from human intestinal cells. Pink and red show areas of SARS-CoV-2 infection.
[Mohammed Shahraz, Sergio Triana/EMBL; Camila Metz-Zumaran/Heidelberg University]
Share
The respiratory tract is given much attention when studying SARS-CoV-2 infection. However, COVID-19 patients show systemic manifestation of the disease in multiple organs. There is clear evidence, for example, of SARS-CoV-2 replication in the gastrointestinal (GI) tract. In an effort to determine the potential for COVID-19 to begin in a person’s gut, and to better understand how human cells respond to SARS-CoV-2, researchers used human intestinal cells to create organoids—3D tissue cultures derived from human cells—which mimic the tissue or organ from which the cells originate. Their single-cell analysis data suggest that SARS-CoV-2 infection can be harbored in a host’s intestines and reveal intricacies in the immune response to SARS-CoV-2.

Related Keywords

Germany , Heidelberg , Baden Wüberg , Lars Steinmetz , Sergio Triana , Theodore Alexandrov , , Molecular Systems Biology , Targeted Perturb Seq , ஜெர்மனி , ஹைடெல்பெர்க் , லார்ஸ் சிடேன்மேடஜ் , மூலக்கூறு அமைப்புகள் உயிரியல் ,

© 2025 Vimarsana